Drug · DIN 00851779
PLENDIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 7, 2024; first marketed December 31, 1992.
- Drug Identification Number (DIN)
- 00851779
- Company (DIN owner)
- Glenwood Gmbh Pharmazeutische ErzeugnisseMunich, --, Germany
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Felodipine C08CA02
- Class
- Human
- Record last updated
- January 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FELODIPINE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 17, 2023: NOC 31872New Drug Submission (NDS) · Administrative: Change in Product Ownership
- February 3, 2000: NOC 1179New Drug Submission (NDS)
Other DINs named PLENDIL
- DIN 00851787 · Marketed
- DIN 02057778 · Marketed